Written and maintained by CASRAI Editorial Board
Last updated
Short answer: Medical supply inventory management is the practice of knowing what supplies a site holds, where each lot sits, and when it expires, so that stock can be used safely and traced if a manufacturer or the FDA recalls it. The records that matter most come from three sources: the identifier on the device label, the storage and expiry rules that apply to laboratory supplies, and recall classifications. This page maps each record to its rule. It is general information, not medical or legal advice.
What medical supply inventory management covers
The operating methods (counting, reorder points and replenishment) are covered on separate CASRAI pages, so this one does not repeat them. See inventory management in healthcare for the supply lifecycle, cycle counting for verifying counts, kanban inventory for signal-based replenishment and par level for the stocking target.
What this page adds is the layer underneath the methods: which pieces of information about each item an inventory has to hold if the site wants to follow label, storage, expiry and recall rules. The sources are the FDA’s UDI Basics page, 42 CFR 493.1252 and 21 CFR 7.3. Full links are in the Sources section.
What the identifier on a device label tells you (UDI)
The FDA describes a unique device identifier (UDI) as a unique numeric or alphanumeric code that generally consists of two parts (FDA, UDI Basics):
- Device identifier (DI): a mandatory, fixed portion of a UDI that identifies the labeler and the specific version or model of a device.
- Production identifier (PI): a conditional, variable portion of a UDI that can identify, when included on the label, the lot or batch number, serial number, expiration date or manufacture date.
The FDA states that the UDI system was established to adequately identify medical devices, with the aim of tracking devices from production through to patient use. For an inventory record this means the DI tells you which product an item is, while lot, serial and expiry information, where the label carries it, comes from the PI. See medical inventory tracking for how those fields are captured item by item and lot numbers for what a lot identifies.
Lab supplies: storage, labelling and expiry (CLIA)
For laboratories certified under CLIA, 42 CFR 493.1252 sets rules for test systems, equipment, instruments, reagents, materials and supplies (Cornell LII copy of the CFR). The paragraphs that bear on inventory are:
- Testing must follow the manufacturer’s instructions (paragraph a).
- The laboratory must define criteria for the conditions that are essential for proper storage of reagents and specimens, and those conditions must be monitored and documented (paragraph b).
- Reagents, solutions, control materials and other supplies must be labelled, including storage requirements, preparation dates and expiration dates (paragraph c).
- Reagents, solutions, culture media, control materials, calibration materials and other supplies must not be used after their expiration date, or if they have deteriorated or are of substandard quality (paragraph d).
This regulation applies to CLIA-certified laboratories. It is not a general rule for every clinic, DME supplier or storeroom, so check which rules cover your own site before relying on it.
Recall readiness
Under 21 CFR 7.3, a recall is a firm’s removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers and against which the agency would initiate legal action. Market withdrawals and stock recoveries are excluded from that definition. The regulation sorts recalls into three classes:
| Class | Situation (21 CFR 7.3) |
|---|---|
| Class I | A reasonable probability that use of, or exposure to, a violative product will cause serious adverse health consequences or death. |
| Class II | Use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse health consequences is remote. |
| Class III | Use of, or exposure to, a violative product is not likely to cause adverse health consequences. |
Editorial interpretation, not a statement of the regulation: finding affected units after a recall notice depends on being able to match a notice to items on the shelf, and the lot, serial and expiry fields from the PI are the natural way to do that. Recording them at receipt is far easier than reconstructing them later.
Records checklist
| Record | Why it is kept | Source |
|---|---|---|
| Device identifier (DI) | Identifies the labeler and the version or model | FDA, UDI Basics |
| Lot or batch, serial number, expiration date (when on the label) | Variable production information carried in the PI | FDA, UDI Basics |
| Storage conditions and monitoring records (CLIA labs) | Conditions must be defined, monitored and documented | 42 CFR 493.1252(b) |
| Label contents: storage, preparation and expiration dates (CLIA labs) | Supplies must be labelled with them | 42 CFR 493.1252(c) |
| Expiry status (CLIA labs) | Expired, deteriorated or substandard materials must not be used | 42 CFR 493.1252(d) |
| Recall class of any notice received | Class I, II or III as defined by the FDA | 21 CFR 7.3 |
Software and DME inventory
Searches for medical supply inventory software and DME inventory software are about tools, not records. The software question is covered in medical inventory management software: what it must track and verify, which lists the fields to check any system against. The records above apply whichever tool, spreadsheet or system a site uses.
Common misunderstandings
- The FDA’s device database holds lot and expiry data. It does not. The FDA states that GUDID holds only the device identifier, not the production identifier, so lot, serial and expiry information has to be captured from the label or from the supplier.
- Every lab supply is covered by the same expiry rule. The CLIA rule quoted above applies to CLIA-certified laboratories.
- A recall is any product removal. The regulation’s definition excludes market withdrawals and stock recoveries.
FAQ
What is medical supply inventory management?
It is the practice of tracking which supplies a site holds, their identifiers, storage conditions and expiry, so they are used within the rules and can be found again if recalled.
What identifiers should a medical supply inventory record?
The FDA describes the device identifier as the fixed part of a UDI and the production identifier as the variable part, which may carry lot or batch number, serial number, expiration date and manufacture date when included on the label.
Can a lab use supplies past their expiry date?
Under 42 CFR 493.1252(d), a CLIA-certified laboratory must not use reagents, solutions, control materials, calibration materials and other supplies that have exceeded their expiration date.
How does inventory data help in a recall?
21 CFR 7.3 defines recall classes by health risk. Matching a notice to items on hand needs recorded identifiers, which is an editorial inference rather than a rule in that section.
Sources
- U.S. Food and Drug Administration, UDI Basics, checked 2026-11-01.
- 42 CFR 493.1252, Standard: Test systems, equipment, instruments, reagents, materials, and supplies, checked 2026-11-01.
- 21 CFR 7.3, Definitions (recall and recall classification), checked 2026-11-01.







